Objective To assess the development of a Positive Child Health Index (PCHI) based on 11 adverse outcomes and evaluate the association of PCHI with quality of life (QoL) scores in a preterm cohort.
Results Among ELGAN children, higher PCHI scores were associated with higher reported QoL scores for all QoL categories. Children with no disorders and a PCHI of 100% had Pediatric Quality of Life Inventory total scores that were 11 points higher than children with 1 or more adverse outcomes (PCHI of <100%). Boys had lower QoL scores for the total, psychosocial, social, and school categories.
Conclusions Positive child health assessed using a quantitative PCHI was associated with QoL across the ELGAN cohort at school age. In the current study, the PCHI encompassed 11 outcomes assessed in ELGANs. P ositive child health is the absence of aberrant conditions or disease along with positive physical, cognitive, and socialemotional well-being, and is a foundational element for later health and wellness. Factors that influence positive health outcomes in children born extremely preterm (<28 weeks of gestation) are understudied. It is known that preterm infants are at increased risk of a variety of adverse developmental and health outcomes. [1] [2] [3] [4] [5] [6] Epidemiologic studies involving children born extremely preterm have focused most often on the prevalence and antecedents of adverse outcomes. 7 Such studies can inform efforts to prevent neurodevelopmental impairment, yet they have had limited impact in mitigating impairment.
An alternative approach to improving the quality of life (QoL) for individuals born extremely preterm would be to identify factors associated with favorable outcomes. A first step in the process to optimize the health of preterm infants is a research definition for positive child health, which is associated with better QoL. The aim of this study was to develop a quantitative framework, the Positive Child Health Index (PCHI), as a metric for assessing positive child health. Data available from the Extremely Low Gestational Age Newborn (ELGAN) study of 10-year-old children born extremely preterm in the US included information about 11 health and developmental disorders. To assess the construct validity of our approach to positive child health, we evaluated the relationship of the number of disorders (the PCHI) to parent-reported QoL. 8 To assess convergent validity, we assessed whether PCHI is higher among girls, because girls born extremely preterm have better neurodevelopmental outcomes than boys. We hypothesized that ELGAN children with a higher PCHI (a lesser number of disorders) would have higher parent-reported QoL and that girls would have a higher PCHI than boys.
Methods
STROBE cohort reporting guidelines were used for this study. 9 From 2002 to 2004, women giving birth at less than 28 weeks of gestation at 1 of 14 academic medical centers in 5 states in the US were asked to enroll in the ELGAN study. Maternal consent was provided either upon hospital admission or before or shortly after delivery. The institutional review board at each participating institution approved procedures used during this study. Of the mothers approached, approximately 85% gave consent for participation in the original ELGAN study, resulting in a cohort of 1249 mothers and 1506 infants.
Ten-Year Follow-Up
As shown in Figure 1 (available at www.jpeds.com), 1198 children (80% of those enrolled) survived to age 10 years. A subset of 966 eligible children were selected for follow-up at 10 years of age because neonatal blood spots had been collected from these children and the primary goal of the ELGAN study was to evaluate associations between neonatal systemic inflammation and cognitive outcome at 10 years of age. Of the 966 children recruited, a total of 889 (92%) participated in some or all of the 10-year evaluations.
Participating families completed 1 visit during which measures reported herein were administered in 3-4 hours, including breaks. While the child was tested, the parent or caregiver completed questionnaires. Eleven disorders were investigated: moderate/severe cognitive impairment, 6 bilateral blindness, 10 hearing impairment, 10 gross motor function impairment, 6 epilepsy, 5 attention deficit/hyperactivity disorder (ADHD), 11 autism, 4 anxiety, depression, asthma, and obesity (ie, body mass index [BMI] of >95th percentile). These items were used to generate a PCHI. Children with no disorders were assigned the highest PCHI of 100%. Any additional disorder reported for a child decreased the PCHI by a percentage based on the number of disorders investigated. Specifically, a 9.1% decrease for each additional disorder was calculated. This calculation based on the inclusion of 11 total disorders (eg, 100/ 11 = 9.1). The maximum number of disorders reported was 8, corresponding with a rounded PCHI score of 27%. Extended methods can be found in the Appendix (available at www.jpeds.com).
Pediatric QoL Inventory. For the QoL measures, a parent or caregiver completed the Pediatric Quality of Life Inventory (PedsQL) 4.0 generic core scales at the 10-year follow-up. The 23-item PedsQL was designed to measure the core dimensions of QoL in areas of physical (8 items), emotional (5 items), social (5 items), and school (5 items) functioning, with each item scored on a 5-point Likert scale. Each dimension is summed and linearly transformed to a 0-100 scale with higher scores indicating better QoL. The PedsQL total summary score incorporates all areas of functioning (23 items), and the PedsQL Psychosocial incorporates the emotional, social, and school functioning areas (15 items). The reliability and the validity of the PedsQL generic core scale have been demonstrated in a large population of enrollees in the Children's Health Insurance Program in California. 8 Statistical Analyses. To assess the relationship between the PCHI and QoL, 2 sets of linear regression models were fit using each QoL outcome (total, psychosocial, physical, emotional, social, school) based on different coding of the PCHI. In the first set of linear regression models, the number of disorders was dichotomized as no disorders vs any disorders (PCHI 100% vs PCHI ≤91%). In the second set of linear regression models, the number of disorders was coded as a categorical variable with separate levels for 0-5 or more disorders (PCHI 100% to PCHI ≤55%). The advantage of this categorical coding of number of disorders rather than a continuous coding is that the impact on QoL is not assumed to be linear in the number of disorders. Furthermore, the PCHI is intrinsically a categorical variable with 11 attainable values. To adjust for potential confounding, we compared the results of models in which no demographic covariates were included and models that included the binary covariates of public insurance and sex, and the continuous covariates of gestational age and birth weight z-score. As an indicator of fetal growth restriction, we used the infant's birth weight z-score, defined as the number of SDs above or below the median weight of infants of the same gestational age in referent samples not delivered for preeclampsia or fetal indications.
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Results
Characteristics of the 889 study participants are shown in Table I . Table II (available at www.jpeds.com) compares the maternal and newborn characteristics of the 889 children who were assessed and the 77 children who were not assessed from among the 966 children eligible for study participation. The rates of missing data among the 889 participants are provided in Table III (available at www.jpeds.com). Although data were missing for some of the individual disorders (0%-4%), each child was assigned a PCHI that reflected their available data.
The majority of mothers (63%) identified as white; 26% identified as black and 10% identified as Hispanic. A total of 41% had received 12 or fewer years of formal education and 35% were eligible for public medical insurance. Of the enrolled mothers, 19% were obese before pregnancy.
Of the ELGANs, 51% were boys and 49% were girls. Twentyone percent were born at 23-24 weeks of gestation. Six percent had fetal growth restriction based on a birth weight z-score of less than −2 SDs.
Health and Developmental Disorders
Prevalence for the 11 health and developmental disorders that we considered in this study ranged from 1% for bilateral blindness to 38% for asthma. Boys were more likely to have moderate/severe cognitive impairment, ADHD, and autism; the other 8 outcomes were not associated with sex (Table IV) . Boys were more likely to have 2 or more disorders and 3 or more Volume 202 • November 2018 disorders than girls ( Table V) . Statistical significance for sex differences in Tables IV and V were derived from logistic regression models that adjusted for public insurance, gestational age, and birth weight z-score. When participants were classified according to the PCHI, 32% of children had a PCHI of 100% (0 of the 11 disorders; Figure 2 ; available at www.jpeds.com).
Parent-Reported QoL as a Function of Disorder Assessment
The PCHI was associated with each PedsQL measure when dichotomized and when evaluated as a multilevel categorical predictor. Linear models were fit without an overall intercept term so that the PCHI parameter estimates correspond with the average PedsQL score for individuals in the associated PCHI category when matched on other characteristics. Covariates were included in each regression analysis to address potential confounding. Within the models, 859 participants are reported in the adjusted analysis (Table VI) and 873 in the unadjusted analysis (Table VII; available at www.jpeds.com) owing to missing demographic data for 14 subjects (public insurance). There is complete agreement between the statistical significance of all tests for group differences between the adjusted and unadjusted analyses for both the dichotomized and coded as a multilevel categorical representation for the PCHI.
In the linear regression model using the dichotomized PCHI, a PCHI of 100% is associated with an 11.2-point increase in PedsQL total score when compared with subjects with PCHI of 91% and less (P < .001) and increases across the other domains of QoL between 6.8 and 13.5 points (P < .001). Girls were estimated to have scores 2.6 points higher on the PedsQL total assessment (P = .012), and statistically significantly higher scores were also observed in the psychosocial, social, and school domains.
In the multilevel categorical predictor, a PCHI of 100% was associated with a 4.9-point increase in the PedsQL total score when compared with subjects with a PCHI of 91% (P < .001), and there was a 7.9-point increase from a PCHI of 91% to a PCHI of 82% (P < .001). Across all domains of the PedsQL, a PCHI of 64% vs 55% and less was associated with an increase of 15.8-21.6 points of QoL (P < .001). The tests for group differences show the magnitude and statistical significance of the differences in each adjacent category of PCHI for each domain of PedsQL. These tests demonstrate a consistent and positive association between the PCHI and QoL that has varying magnitudes across PCHI groups and domains of QoL. The PedsQL domains for psychosocial, social, and school (P < .05) were significantly higher for girls and the PedsQL total (P = .051) was borderline significantly higher for girls.
Discussion
The aim of this study was to develop a quantitative index for defining positive child health using data from the ELGAN cohort, a large and diverse cohort of 10-year-old children born extremely preterm in the US. We considered parent-reported QoL and data on the absence or presence of asthma, obesity, and 9 neurodevelopmental and neurobehavioral outcomes, including cognitive impairment, bilateral blindness, hearing impairment, gross motor function impairment, epilepsy, ADHD, autism, anxiety, and depression. From these 11 disorders, we established a quantitative tool, the PCHI, and assessed whether high PCHI scores captured children with high QoL scores. The usefulness of the PCHI is supported by our finding that it was positively associated with parent-reported QoL.
PCHI scores were higher among ELGAN girls compared with boys, as would be expected based on the higher prevalence of some developmental impairments among boys. Preterm boys have higher risks for autism, ADHD, and cognitive impairment compared with girls, and similar sex differences have been reported by other investigators. 2, 6, [14] [15] [16] [17] The reasons for the greater vulnerability of boys are not well-understood. Irrespective of the mechanisms that underlie the higher risk among boys, the implication for clinicians is that boys born preterm are a particularly vulnerable group that warrants enhanced monitoring of health and development. In addition to lower PCHI scores, boys had lower QoL scores for the total, psychosocial, social, and school categories. Success in both domains probably depends in part on cognitive abilities and, in the ELGAN cohort, cognitive impairment is more frequent among boys than girls. In addition, the increased prevalence of ADHD and autism among ELGAN boys likely impact boys' performances in school and social aspects of daily life. Other QoL studies have shown that girls tend to score lower in physical functioning healthrelated QoL compared with boys, 18 although some studies do not observe any sex differences in health-related QoL. 19 The National Research Council defines child health as the extent to which children can develop and realize their potential, satisfy their needs, and develop the capacities that allow them to interact successfully with their surrounding environments. 20 Similarly, the World Health Organization defines child heath as a state of complete physical, mental, and social well-being. 21 Although the absence of any of the disorders assessed for our study should not be regarded as the sole indicator of positive child health, the PCHI identified many of the children with high parent-reported QoL, and because positive child health is an outcome of interest in National Institutes of Health's recently launched the Environmental Influences on Child Health Outcomes program, the PCHI could be used to identify children with positive health and help to identify factors that promote positive child health outcomes in future studies.
We found that 32% of our extremely high-risk ELGAN cohort were free from all 11 of the disorders that we examined (a PCHI of 100%) and were more likely to have higher QoL scores. The focus and goal of future analyses will be to identify early life antecedents associated with their high positive health results at 10 years of age using the established PCHI.
An important limitation of our study is that the outcomes were obtained from a cohort evaluated primarily for neurodevelopmental outcomes, rather than a broader profile of disorders, such as cardiometabolic and respiratory illnesses. In addition, we did not collect precise information about the severity of most of the disorders we studied, except for cognitive impairment. Thus, a diagnosis of asthma probably included a wide range of severity, whereas for most of the neurodevelopmental outcomes, the diagnosis included only the most severely affected individuals. We expect that the severity of an impairment could be related to the QoL and the likelihood of positive child health. Thus, we posit that a more informative approach than the one described herein would include a more detailed evaluation of the severity of asthma, obesity, psychiatric, and neurodevelopmental disorders. Last, of the original 966 participants, the 77 study participants lost to follow-up were more likely to have indicators of social disadvantage, such as eligibility for public assistance. The bias from children lost to follow-up would, therefore, be expected to result in an underestimation of adverse outcomes in the cohort. However, given the low frequency of children lost to followup in this cohort (8%), the magnitude of this bias was likely small. Despite these limitations, the significant relationship of the PCHI with QoL shows promise for its use in measuring positive child health outcomes. Current ELGAN follow-up studies are collecting child-reported QoL measures at ages 15 and older, because the relationship between parent and child QoL reports has been shown to be complex. 22, 23 Strengths of Values are n (%) unless otherwise noted. *Adjusted for public insurance, and child gestational age and birth weight Z-score. our study include a large sample that was relatively diverse with respect to sociodemographic attributes and that neurodevelopmental assessments were performed by individuals who were blinded to the child's parent-reported QoL. This study revealed that, at 10 years of age, ELGAN children with overall fewer disorders and higher PCHI had higher parent-reported QoL, and that 32% of the cohort had none of the disorders examined. In addition, girls were more likely to have a higher PCHI and higher QoL than boys for PedsQL total, psychosocial, social, and school categories. The approach we used to assess positive child health lays a foundation to identify characteristics associated with optimal outcomes among children born extremely preterm at high risk for adverse outcomes. A PCHI, such as the one created herein, can be used to help further understand influencing factors on positive child health. Additional efforts to utilize this index across populations warrants consideration. ■ 
Appendix
Extended Methods
Extremely Low Gestational Age Newborn Study Participants. A trained research nurse interviewed mothers using a structured questionnaire shortly after the time of delivery to ascertain sociodemographic information, such as maternal age, years of education, eligibility for public insurance, and mother's prepregnancy weight and height. Medical records were reviewed to collect medical information about the infant and mother. Prepregnancy body mass index (BMI) was calculated as weight/height 2 1 Nonverbal subscale at the time of each study participant's assessment at 10 years of age.
Gestational ages were estimated based on the dates of embryo retrieval, intrauterine insemination, or fetal ultrasound examination before the 14th week of gestation. An infant's birth weight z-score is defined as the number of SDs above or below the median weight of infants of the same gestational age in referent samples not delivered for preeclampsia or fetal indications.
2,3
Extremely Low Gestational Age Newborn 10-Year Follow-Up Moderate/Severe Cognitive Impairment. General cognitive ability (or IQ) was assessed with the School-Age Differential Ability Scales-II verbal and nonverbal reasoning scales. 4 Because resulting verbal and nonverbal IQ scores were strongly correlated, the mean of these 2 measures was used as an estimate of the general cognitive ability. 5 Using latent profile analysis, 4 categories of cognitive function were identified: normal (34% of cohort), low-normal (41%), moderately impaired (17%), and severely impaired (8%). 6 For the purposes of this study, moderate to severe cognitive impairment was defined as being in either the moderately impaired or severely impaired cognitive function group, and the absence of moderate to severe impairment was defined as being in either the low-normal or normal group.
Bilateral Blindness, Hearing Impairment, and Gross Motor Function Impairment. A child was considered to have visual impairment if the parent reported uncorrectable functional blindness in both eyes and hearing impaired if the parent reported use of hearing aid, cochlear implant, or special services for hearing impaired individuals. Gross motor function impairment was defined as a level 2 or higher on the Gross Motor Function Classification System. Epilepsy. Seizures were identified using a 2-staged process that included the administration of a brief seizure screen to parents about their child and, when positive, a follow-up structured interview by an epileptologist. 8 A seizure diagnosis required the consensus of 2 epileptologists. Epilepsy was defined as 2 or more seizures after the neonatal period that were not provoked by fever, trauma, or infection of the central nervous system. Identification methods can be found in a previous publication.
5
Attention Deficit/Hyperactivity Disorder. The parent or caregiver completed the Child Symptom Inventory (CSI-4) Parent Checklist, fourth edition, 9, 10 and the child's current teacher was asked to complete the CSI-4 Teacher Checklist. Classifications of attention deficit/hyperactivity disorder (ADHD) were made based on norm-based cutoff scores provided in the CSI-4 manual. Children successfully enrolled and evaluated were not considered to meet diagnostic criteria, but rather a research classification of significant ADHD symptom presentation. To parallel clinical decision making, 11 3 possible contexts in which ADHD symptoms were present were considered. Two of the contexts were taken from the parent and teacher ADHD symptoms as reported on the CSI-4, and a third context was based on the parent's indication at interview of the child having been diagnosed previously by a clinician to have ADHD. Traditionally, physician assessment of ADHD precedes treatment with stimulants and the physician's diagnosis of ADHD is typically based equally or more on parent and teacher report than their own observations 12 ; therefore, we regarded this finding as pertinent to our research classification. Participants were included in the ADHD symptom group if they meet criteria in any 2 of the 3 contexts.
Anxiety and Depression. For the identification of anxiety disorders and depressive disorders, parents completed CSI-4 Parent Checklist and teachers completed the CSI-4 Teacher Checklist. 9, 10 Of the 889 children who were enrolled successfully, 871 had a CSI-4 measure of depression and anxiety completed by a parent and 640 also had a teacher-completed CSI-4.
The forms asked for details about generalized anxiety, social phobia, depressive disorder, or dysthymic disorder. Only the parent form asked for details about separation anxiety. Consequently, parent-identified anxiety was defined as screening positive on generalized anxiety disorder, social phobia disorder, or separation anxiety disorder, whereas teacher-identified anxiety was defined as screening positive on generalized anxiety disorder or social phobia disorder. For the identification of depressive disorders, both parent-and teacher-identified depression is defined as screening positive on depressive disorder or dysthymic disorder.
Autism. Diagnostic assessment of autism spectrum disorder (ASD) was conducted with 3 well-validated measures administered sequentially. 13 The first was the Social Communication Questionnaire 14 administered with a screen-in score of 11 or greater to increase its sensitivity relative to the standard criterion score of 15 or greater. Children who met the Social Communication Questionnaire criterion were then assessed with the Autism Diagnostic Interview-Revised. 15 All children who met the Autism Diagnostic Interview-Revised criteria for autism or ASD, 16 or who had a prior clinical diagnosis of ASD, and/ or exhibited symptoms of ASD during cognitive testing (according to the site psychologist) were then assessed with the Autism Diagnostic Observation Schedule, Second Version, 17 which was the criterion measure of ASD in this study.
Asthma.
A positive diagnosis of asthma was determined on the answers received for the following question on parent completed forms: Since age 2 years, have you been told by a doctor or other health professional that your child has or had asthma?
BMI. Weight and height were gathered by study personnel during the scheduled comprehensive assessment, and BMI was calculated using the following formula: BMI = weight (kg)/ height (m) 2 . BMI Z-scores were determined using the Statistical Analysis Software program based on current growth charts published by the Centers for Disease Control and Prevention (SAS Institute Inc, Cary, North Carolina). 
